Bio-Techne Corp (NASDAQ:TECH) — Stock Price
Bio-Techne Corp (NASDAQ:TECH) is currently trading at $72.61 USD, up 0.06% today. Over the past 52 weeks, shares have ranged between $43.30 and $72.61. This page tracks Bio-Techne Corp's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see TECH company net worth.
Bio-Techne Corp (TECH) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bio-Techne Corp's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bio-Techne Corp Income Statement — Revenue, Profit & Earnings by Year
Bio-Techne Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | $1.22 Billion | $1.22 Billion | $1.16 Billion | $1.14 Billion | $1.11 Billion |
| Cost of Revenue | $415.97 Million | $429.36 Million | $389.33 Million | $366.89 Million | $349.10 Million |
| Gross Profit | $799.07 Million | $790.27 Million | $769.73 Million | $769.82 Million | $756.50 Million |
| Research & Development | $94.77 Million | $99.50 Million | $96.66 Million | $92.49 Million | $87.14 Million |
| SG&A | $452.42 Million | $415.10 Million | $393.32 Million | $352.44 Million | $339.00 Million |
| Total Operating Expenses | $547.18 Million | $688.02 Million | $563.04 Million | $470.87 Million | $459.91 Million |
| Operating Income | $251.89 Million | $102.25 Million | $206.69 Million | $298.94 Million | $296.59 Million |
| EBITDA | $343.44 Million | $216.88 Million | $313.14 Million | $457.11 Million | $413.76 Million |
| EBIT | $246.09 Million | $106.97 Million | $201.43 Million | $349.87 Million | $312.69 Million |
| Interest Expense | $5.41 Million | $8.51 Million | $15.74 Million | $11.21 Million | $11.31 Million |
| Income Before Tax | $240.68 Million | $98.46 Million | $185.69 Million | $338.66 Million | $301.39 Million |
| Income Tax Expense | $58.82 Million | $25.06 Million | $17.58 Million | $53.22 Million | $38.29 Million |
| Net Income | $181.86 Million | $73.40 Million | $168.10 Million | $285.26 Million | $272.05 Million |
Bio-Techne Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bio-Techne Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | $2.68 Billion | $2.56 Billion | $2.70 Billion | $2.64 Billion | $2.29 Billion |
| Total Current Assets | $744.40 Million | $608.30 Million | $617.42 Million | $621.48 Million | $605.56 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | $0.00 | $1.07 Million | $23.74 Million | $74.46 Million |
| Net Receivables | $220.50 Million | $206.88 Million | $241.39 Million | $218.47 Million | $194.55 Million |
| Inventory | $195.74 Million | $189.45 Million | $179.73 Million | $171.64 Million | $141.12 Million |
| Property, Plant & Equipment | — | — | — | $226.20 Million | $288.80 Million |
| Goodwill | $975.36 Million | $980.93 Million | $972.66 Million | $872.74 Million | $822.10 Million |
| Total Liabilities | $570.77 Million | $639.06 Million | $635.02 Million | $672.18 Million | $593.79 Million |
| Total Current Liabilities | $163.70 Million | $175.85 Million | $159.38 Million | $128.51 Million | $176.02 Million |
| Long-term Debt | $200.00 Million | $346.00 Million | $319.00 Million | $350.00 Million | $243.41 Million |
| Net Debt | $24.38 Million | $281.87 Million | $267.75 Million | $274.39 Million | $153.40 Million |
| Total Stockholder Equity | $2.11 Billion | $1.92 Billion | $2.07 Billion | $1.97 Billion | $1.70 Billion |
| Retained Earnings | $1.14 Billion | $1.07 Billion | $1.33 Billion | $1.31 Billion | $1.12 Billion |
Bio-Techne Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bio-Techne Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | $292.07 Million | $287.56 Million | $298.98 Million | $254.39 Million | $325.27 Million |
| Capital Expenditures | $28.85 Million | $31.01 Million | $62.88 Million | $38.24 Million | $44.91 Million |
| Free Cash Flow | $263.22 Million | $256.55 Million | $236.10 Million | $216.15 Million | $280.36 Million |
| Investing Cash Flow | $-18.19 Million | $-35.18 Million | $-203.03 Million | $-265.65 Million | $-96.85 Million |
| Financing Cash Flow | $-169.11 Million | $-253.91 Million | $-122.40 Million | $22.62 Million | $-242.85 Million |
| Dividends Paid | $49.92 Million | $50.39 Million | $50.42 Million | $50.28 Million | $50.19 Million |
| Stock-Based Compensation | $41.37 Million | $40.83 Million | $38.04 Million | $39.23 Million | $42.18 Million |
| Depreciation | $97.36 Million | $109.90 Million | $111.71 Million | $107.24 Million | $101.07 Million |
| Change in Cash | $102.53 Million | $10.39 Million | $-28.78 Million | $8.00 Million | $-26.52 Million |
Bio-Techne Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Bio-Techne Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Nov 04, 2026 | — | 0.40 | — |
| Aug 12, 2026 | 0.49 | 0.46 | +6.52% |
| May 06, 2026 | 0.53 | 0.53 | +0.00% |
| Feb 04, 2026 | 0.46 | 0.43 | +6.98% |
| Nov 05, 2025 | 0.36 | 0.36 | +0.00% |
| Aug 06, 2025 | 0.53 | 0.50 | +6.00% |
| May 07, 2025 | 0.56 | 0.51 | +9.80% |
| Feb 05, 2025 | 0.42 | 0.39 | +7.69% |